Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying-Chu Shih

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Oncology Reports|December 28, 2025
[Corrigendum] Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR‑30c in breast cancerMeng-Chi Yen, Ying-Chu Shih, Ya-Ling Hsu, et al.
Oncology Reports|December 29, 2015
Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR-30c in breast cancerMeng-Chi Yen, Ying-Chu Shih, Ya-Ling Hsu, et al.
Journal of the Chinese Medical Association : JCMA|October 5, 2021
Synergistic therapeutic effect of low-dose bevacizumab with cisplatin-based chemotherapy for advanced or recurrent cervical cancerChia-Hao Liu, Yen-Hsuan Kung, Jeff Chien-Fu Lin, et al.
Chinese Medicine|August 28, 2012
Effects of alpha-mangostin on the expression of anti-inflammatory genes in U937 cellsSzu-Hsiu Liu, Lain-Tze Lee, Nai-Yun Hu, et al.
European Radiology|May 18, 2022
Comparison of the O-RADS and ADNEX models regarding malignancy rate and validity in evaluating adnexal lesionsGuan-Yeu Chen, Teh-Fu Hsu, I-San Chan, et al.
Bioorganic & Medicinal Chemistry|June 24, 2010
Synthesis and structure-activity relationship of 6-arylureido-3-pyrrol-2-ylmethylideneindolin-2-one derivatives as potent receptor tyrosine kinase inhibitorsRahul R Khanwelkar, Grace Shiahuy Chen, Hsiao-Chun Wang, et al.
Bioorganic & Medicinal Chemistry Letters|September 14, 2010
Novel azulene-based derivatives as potent multi-receptor tyrosine kinase inhibitorsChih-Hung Chen, On Lee, Chung-Niang Yao, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Oncology Reports|December 28, 2025
[Corrigendum] Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR‑30c in breast cancerMeng-Chi Yen, Ying-Chu Shih, Ya-Ling Hsu, et al.
Oncology Reports|December 29, 2015
Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR-30c in breast cancerMeng-Chi Yen, Ying-Chu Shih, Ya-Ling Hsu, et al.
Journal of the Chinese Medical Association : JCMA|October 5, 2021
Synergistic therapeutic effect of low-dose bevacizumab with cisplatin-based chemotherapy for advanced or recurrent cervical cancerChia-Hao Liu, Yen-Hsuan Kung, Jeff Chien-Fu Lin, et al.
Chinese Medicine|August 28, 2012
Effects of alpha-mangostin on the expression of anti-inflammatory genes in U937 cellsSzu-Hsiu Liu, Lain-Tze Lee, Nai-Yun Hu, et al.
European Radiology|May 18, 2022
Comparison of the O-RADS and ADNEX models regarding malignancy rate and validity in evaluating adnexal lesionsGuan-Yeu Chen, Teh-Fu Hsu, I-San Chan, et al.
Bioorganic & Medicinal Chemistry|June 24, 2010
Synthesis and structure-activity relationship of 6-arylureido-3-pyrrol-2-ylmethylideneindolin-2-one derivatives as potent receptor tyrosine kinase inhibitorsRahul R Khanwelkar, Grace Shiahuy Chen, Hsiao-Chun Wang, et al.
Bioorganic & Medicinal Chemistry Letters|September 14, 2010
Novel azulene-based derivatives as potent multi-receptor tyrosine kinase inhibitorsChih-Hung Chen, On Lee, Chung-Niang Yao, et al.
Pageof 2